Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $891.82 million. The enterprise value is $432.88 million.

Market Cap	891.82M
Enterprise Value	432.88M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BCAX has 54.61 million shares outstanding. The number of shares has increased by 6,191.81% in one year.

Current Share Class	54.61M
Shares Outstanding	54.61M
Shares Change (YoY)	+6,191.81%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	51.48%
Float	24.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.99
P/TBV Ratio	1.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.80, with a Debt / Equity ratio of 0.01.

Current Ratio	25.80
Quick Ratio	25.34
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.71% and return on invested capital (ROIC) is -24.00%.

Return on Equity (ROE)	-32.71%
Return on Assets (ROA)	-22.85%
Return on Invested Capital (ROIC)	-24.00%
Return on Capital Employed (ROCE)	-27.75%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $310,000 in taxes.

Income Tax	310,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.95%
50-Day Moving Average	14.15
200-Day Moving Average	12.55
Relative Strength Index (RSI)	48.52
Average Volume (20 Days)	767,040

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-121.07M
Pretax Income	-102.36M
Net Income	-102.67M
EBITDA	-121.00M
EBIT	-121.07M
Earnings Per Share (EPS)	-$2.35

Balance Sheet

The company has $436.61 million in cash and $2.24 million in debt, giving a net cash position of $434.37 million or $7.95 per share.

Cash & Cash Equivalents	436.61M
Total Debt	2.24M
Net Cash	434.37M
Net Cash Per Share	$7.95
Equity (Book Value)	435.20M
Book Value Per Share	7.98
Working Capital	427.16M

Cash Flow

In the last 12 months, operating cash flow was -$100.96 million and capital expenditures -$48,000, giving a free cash flow of -$101.00 million.

Operating Cash Flow	-100.96M
Capital Expenditures	-48,000
Free Cash Flow	-101.00M
FCF Per Share	-$1.85

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6,191.81%
Shareholder Yield	-6,191.81%
Earnings Yield	-11.84%
FCF Yield	-11.65%

Analyst Forecast

The average price target for BCAX is $25.60, which is 56.77% higher than the current price. The consensus rating is "Buy".

Price Target	$25.60
Price Target Difference	56.77%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2